AlterG, Inc.

AlterG, Inc. specializes in advanced rehabilitation technologies, primarily known for its AlterG® Anti-Gravity Treadmill™, which helps users achieve pain-free movement for rehabilitation and training purposes. Founded in 2005, AlterG, Inc. is headquartered in Fremont, US.

The company focuses on advanced rehabilitation technology and has previously pivoted its strategy by integrating into the neurorehabilitation sector. The current CEO is Anirudh Dhacholia. AlterG has successfully raised a total of USD 5. 59 mn across 9 deals, with the latest funding being a Venture Debt round of USD 8.

00 mn from Cortland Credit Group. AlterG, now part of Lifeward, specializes in advanced rehabilitation technology with its flagship product being the AlterG® Anti-Gravity Treadmill™. This innovative device utilizes patented Differential Air Pressure (DAP) technology to precisely reduce gravitational forces on the user by up to 80%, enabling pain-free movement for rehabilitation and training. The treadmills are designed for various applications, including physical therapy, sports performance, and rehabilitation for patients recovering from orthopedic injuries, neurological conditions, chronic diseases, or managing obesity.

Since their introduction in 2005, AlterG treadmills have been deployed in over 5,000 facilities globally, including hospitals, rehabilitation centers, and sports performance facilities, catering to a diverse clientele that includes clinicians, athletes, and patients. The products are marketed in various international markets, emphasizing their versatility and effectiveness across different patient demographics. AlterG's revenue model primarily revolves around the sale and lease of its Anti-Gravity Treadmills, marketed to healthcare providers, sports teams, and rehabilitation facilities. Transactions typically occur through direct sales to institutions and organizations, as well as through leasing arrangements that allow clients to integrate the technology into their facilities without significant upfront costs.

The company offers a range of models, including the AlterG NEO and the PRO series, positioned at various price points to accommodate different market needs. Additionally, ongoing support and maintenance services are provided, enhancing the value proposition for clients. The structured pricing plans reflect the capabilities and technological advancements of the products, catering to institutions looking to improve patient outcomes through innovative rehabilitation solutions. In August 2023, Rewalk Robotics Ltd.

agreed to acquire AlterG, Inc. for approximately USD 19. 0 mn in cash. This acquisition aims to enhance Rewalk Robotics Ltd.

's customer-facing capabilities and expand its growth potential by integrating AlterG's neurorehabilitation product portfolio. The acquisition will support AlterG's ongoing strategy to innovate and expand their product offerings, as well as increase market reach into new regions.